Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000059

EVP, Chf Clinical Develop Ofcr sold 8,000 shares at $53.50 ($427,999)

  • EVP, Chf Clinical Develop Ofcr acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Schneider Eugene · EVP, Chf Clinical Develop Ofcr

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-12 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $32.60 $260,800 46,170 D
2024-01-12 Sale : show line 2 in the form 10b5-1 −8,000 $53.50 $427,999 38,170 D
Open-market sales · 8,000 sh · avg $53.50 · $427,999

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-01-12 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −8,000 $32.60 2032-01-02 8,000 24,265 D
2024-01-15 Grant or award : show line 4 in the form 10b5-1 Performance Restricted Stock Units +17,000 $0.00 17,000 43,437 D
2024-01-15 Grant or award : show line 5 in the form 10b5-1 Restricted Stock Unit +20,400 $0.00 20,400 60,470 D
Loading xslF345X05/edgardoc.xml…